Advent Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Advent Pharma has a total shareholder equity of BDT1.5B and total debt of BDT75.2M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are BDT1.9B and BDT428.5M respectively. Advent Pharma's EBIT is BDT133.6M making its interest coverage ratio 10.4. It has cash and short-term investments of BDT4.3M.
Key information
5.1%
Debt to equity ratio
৳75.16m
Debt
Interest coverage ratio | 10.4x |
Cash | ৳4.32m |
Equity | ৳1.47b |
Total liabilities | ৳428.51m |
Total assets | ৳1.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ADVENT's short term assets (BDT246.2M) exceed its short term liabilities (BDT231.0M).
Long Term Liabilities: ADVENT's short term assets (BDT246.2M) exceed its long term liabilities (BDT197.5M).
Debt to Equity History and Analysis
Debt Level: ADVENT's net debt to equity ratio (4.8%) is considered satisfactory.
Reducing Debt: ADVENT's debt to equity ratio has increased from 3.2% to 5.1% over the past 5 years.
Debt Coverage: ADVENT's debt is well covered by operating cash flow (290.4%).
Interest Coverage: ADVENT's interest payments on its debt are well covered by EBIT (10.4x coverage).